Ignite Creation Date:
2025-12-25 @ 5:00 AM
Ignite Modification Date:
2025-12-26 @ 4:01 AM
Study NCT ID:
NCT00510718
Status:
COMPLETED
Last Update Posted:
2019-10-03
First Post:
2007-07-31
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Phase 1 Study of MDV3100 in Patients With Castration-Resistant (Hormone-Refractory) Prostate Cancer
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-07-23
Start Date Type:
ACTUAL
Primary Completion Date:
2008-12-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-04-02
Completion Date Type:
ACTUAL
First Submit Date:
2007-07-31
First Submit QC Date:
None
Study First Post Date:
2007-08-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-03-20
Results First Submit QC Date:
None
Results First Post Date:
2019-10-03
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-09-10
Last Update Post Date:
2019-10-03
Last Update Post Date Type:
ACTUAL